Stay updated on Pembrolizumab in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Metastatic NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added a Locations section with a California site and updated the page revision to v3.3.3; the prior California Locations listing was removed.
    Difference
    0.2%
    Check dated 2025-12-23T09:00:54.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Updated: Study Protocol and Statistical Analysis Plan to revision v3.3.2, replacing v3.3.1. This is an administrative document revision and does not alter core trial details or reported results on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:27:38.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.1; no visible changes to study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:43:03.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The government funding lapse notice has been removed from the page, while the study details and general content remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:50:01.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    No significant differences in the study details or outcomes between the screenshots; the page content remains the same except for minor formatting variations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:17:18.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-05T09:59:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Metastatic NSCLC Clinical Trial page.